Log In
Print
BCIQ
Print
Print this Print this
 

RHB-105 (formerly Heliconda)

  Manage Alerts
Collapse Summary General Information
Company RedHill Biopharma Ltd.
DescriptionFixed-dose combination of the antibiotics rifabutin and amoxicillin and the proton pump inhibitor (PPI) omeprazole
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationHelicobacter
Indication DetailsTreat Helicobacter pylori infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today